2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 18:38, 31 October 2023
, 31 October 2023→Clinical Trials
| Line 209: | Line 209: | ||
* 900 mg/day oral dose did not give significantly better efficacy than 600 mg/day dose | * 900 mg/day oral dose did not give significantly better efficacy than 600 mg/day dose | ||
|- | |- | ||
| | | {{#pmid:35215405|#pmid_text}} | ||
| | | | ||
| | | | ||